CoChat

Molecular Mechanisms in Pentanucleotide Repeat Diseases

Loureiro, Joana R., Castro, Ana F., Figueiredo, Ana S., Silveira, Isabel · 2022 · Cells
Cited by 28

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The number of neurodegenerative diseases resulting from repeat expansion has increased extraordinarily in recent years. In several of these pathologies, the repeat can be transcribed in RNA from both DNA strands producing, at least, one toxic RNA repeat that causes neurodegeneration by a complex mechanism. Recently, seven diseases have been found caused by a novel intronic pentanucleotide repeat in distinct genes encoding proteins highly expressed in the cerebellum. These disorders are clinically heterogeneous being characterized by impaired motor function, resulting from ataxia or epilepsy. The role that apparently normal proteins from these mutant genes play in these pathologies is not known. However, recent advances in previously known spinocerebellar ataxias originated by abnormal non-coding pentanucleotide repeats point to a gain of a toxic function by the pathogenic repeat-containing RNA that abnormally forms nuclear foci with RNA-binding proteins. In cells, RNA foci have been shown to be formed by phase separation. Moreover, the field of repeat expansions has lately achieved an extraordinary progress with the discovery that RNA repeats, polyglutamine, and polyalanine proteins are crucial for the formation of nuclear membraneless organelles by phase separation, which is perturbed when they are expanded. This review will cover the amazing advances on repeat diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11020205

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 174

  1. Malik, 2021, Author Correction: Molecular mechanisms underlying nucleotide repeat expansion disorders, Nat. Rev. Mol. Cell Biol., 22, 644, 10.1038/s41580-021-00396-0 · doi:10.1038/s41580-021-00396-0
  2. Morriss, 2017, Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions, Hum. Genet., 136, 1247, 10.1007/s00439-017-1807-6 · DOI
  3. Basu, 2020, Unblending of Transcriptional Condensates in Human Repeat Expansion Disease, Cell, 181, 1062, 10.1016/j.cell.2020.04.018 · DOI · Paper page
  4. Paul, 2018, Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration, Nat. Commun., 9, 3648, 10.1038/s41467-018-06041-3 · DOI
  5. Loureiro, 2016, Unstable repeat expansions in neurodegenerative diseases: Nucleocytoplasmic transport emerges on the scene, Neurobiol. Aging, 39, 174, 10.1016/j.neurobiolaging.2015.12.007 · DOI
  6. Nguyen, 2019, Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease, Annu. Rev. Neurosci., 42, 227, 10.1146/annurev-neuro-070918-050405 · DOI
  7. Sznajder, L.J., and Swanson, M.S. (2019). Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy. Int. J. Mol. Sci., 20. · DOI · Paper page
  8. Lalioti, 1997, Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy, Nature, 386, 847, 10.1038/386847a0 · DOI · Paper page
  9. LaCroix, 2019, GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome, Am. J. Hum. Genet., 104, 35, 10.1016/j.ajhg.2018.11.005 · DOI · Paper page
  10. Holmes, 1999, Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12, Nat. Genet., 23, 391, 10.1038/70493 · DOI · Paper page
  11. Hwang, 2015, Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12, Mov. Disord., 30, 1813, 10.1002/mds.26348 · DOI
  12. Verkerk, 1991, Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome, Cell, 65, 905, 10.1016/0092-8674(91)90397-H · DOI · Paper page
  13. Knight, 1993, Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation, Cell, 74, 127, 10.1016/0092-8674(93)90300-F · DOI · Paper page
  14. Metsu, S., Rooms, L., Rainger, J., Taylor, M.S., Bengani, H., Wilson, D.I., Chilamakuri, C.S., Morrison, H., Vandeweyer, G., and Reyniers, E. (2014). FRA2A is a CGG repeat expansion associated with silencing of AFF3. PLoS Genet., 10. · DOI
  15. Metsu, 2014, A CGG-repeat expansion mutation in ZNF713 causes FRA7A: Association with autistic spectrum disorder in two families, Hum. Mutat., 35, 1295
  16. Debacker, 2007, The molecular basis of the folate-sensitive fragile site FRA11A at 11q13, Cytogenet. Genome Res., 119, 9, 10.1159/000109612 · DOI
  17. Winnepenninckx, 2007, CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1, Am. J. Hum. Genet., 80, 221, 10.1086/510800 · DOI · Paper page
  18. Richmond, 2019, Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS, N. Engl. J. Med., 380, 1433, 10.1056/NEJMoa1806627 · DOI · Paper page
  19. Hagerman, 2001, Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X, Neurology, 57, 127, 10.1212/WNL.57.1.127 · DOI · Paper page
  20. Cronister, 1991, Heterozygous fragile X female: Historical, physical, cognitive, and cytogenetic features, Am. J. Med. Genet., 38, 269, 10.1002/ajmg.1320380221 · DOI · Paper page
  21. Tian, 2019, Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders, Am. J. Hum. Genet., 105, 166, 10.1016/j.ajhg.2019.05.013 · DOI · Paper page
  22. Sone, 2019, Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease, Nat. Genet., 51, 1215, 10.1038/s41588-019-0459-y · DOI · Paper page
  23. Ishiura, 2019, Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease, Nat. Genet., 51, 1222, 10.1038/s41588-019-0458-z · DOI · Paper page
  24. Campuzano, 1996, Friedreich’s ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion, Science, 271, 1423, 10.1126/science.271.5254.1423 · DOI · Paper page
  25. Mackenzie, 2011, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS, Neuron, 72, 245, 10.1016/j.neuron.2011.09.011 · DOI · Paper page
  26. Renton, 2011, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, 72, 257, 10.1016/j.neuron.2011.09.010 · DOI · Paper page
  27. Matsuura, 2000, Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10, Nat. Genet., 26, 191, 10.1038/79911 · DOI · Paper page
  28. Quintans, 2012, ‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: Clinical and genetic characterization, Brain, 135, 1423, 10.1093/brain/aws069 · DOI · Paper page
  29. Kobayashi, 2011, Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement, Am. J. Hum. Genet., 89, 121, 10.1016/j.ajhg.2011.05.015 · DOI · Paper page
  30. Liquori, 2001, Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9, Science, 293, 864, 10.1126/science.1062125 · DOI · Paper page
  31. Wieben, E.D., Aleff, R.A., Tosakulwong, N., Butz, M.L., Highsmith, W.E., Edwards, A.O., and Baratz, K.H. (2012). A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS ONE, 7. · DOI · Paper page
  32. Sato, 2009, Spinocerebellar ataxia type 31 is associated with “inserted” penta-nucleotide repeats containing (TGGAA)n, Am. J. Hum. Genet., 85, 544, 10.1016/j.ajhg.2009.09.019 · DOI · Paper page
  33. Seixas, 2017, A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia, Am. J. Hum. Genet., 101, 87, 10.1016/j.ajhg.2017.06.007 · DOI · Paper page
  34. Ishiura, 2018, Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy, Nat. Genet., 50, 581, 10.1038/s41588-018-0067-2 · DOI · Paper page
  35. Corbett, 2019, Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2, Nat. Commun., 10, 4920, 10.1038/s41467-019-12671-y · DOI · Paper page
  36. Florian, 2019, Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3, Nat. Commun., 10, 4919, 10.1038/s41467-019-12763-9 · DOI · Paper page
  37. Yeetong, 2019, TTTCA repeat insertions in an intron of YEATS2 in benign adult familial myoclonic epilepsy type 4, Brain, 142, 3360, 10.1093/brain/awz267 · DOI
  38. Bragg, 2017, Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1, Proc. Natl. Acad. Sci. USA, 114, E11020, 10.1073/pnas.1712526114 · DOI · Paper page
  39. Mahadevan, 1992, Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene, Science, 255, 1253, 10.1126/science.1546325 · DOI · Paper page
  40. Brook, 1992, Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member, Cell, 68, 799, 10.1016/0092-8674(92)90154-5 · DOI · Paper page
  41. Seixas, 2012, Loss of junctophilin-3 contributes to huntington disease-like 2 pathogenesis, Ann. Neurol., 71, 245, 10.1002/ana.22598 · DOI · Paper page
  42. Wilburn, 2011, An antisense CAG repeat transcript at JPH3 locus med.diates expanded polyglutamine protein toxicity in Huntington’s disease-like 2 mice, Neuron, 70, 427, 10.1016/j.neuron.2011.03.021 · DOI · Paper page
  43. Holmes, 2001, A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2, Nat. Genet., 29, 377, 10.1038/ng760 · DOI · Paper page
  44. Koob, 1999, An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8), Nat. Genet., 21, 379, 10.1038/7710 · DOI · Paper page
  45. Moseley, 2006, Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8, Nat. Genet., 38, 758, 10.1038/ng1827 · DOI · Paper page
  46. Koide, 1994, Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA), Nat. Genet., 6, 9, 10.1038/ng0194-9 · DOI · Paper page
  47. The Huntington’s Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983. · DOI · Paper page
  48. Wilson, 1991, Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy, Nature, 352, 77, 10.1038/352077a0 · DOI · Paper page
  49. Imbert, 1996, Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats, Nat. Genet., 14, 285, 10.1038/ng1196-285 · DOI · Paper page
  50. Kawaguchi, 1994, CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1, Nat. Genet., 8, 221, 10.1038/ng1194-221 · DOI · Paper page
  51. Zhuchenko, 1997, Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel, Nat. Genet., 15, 62, 10.1038/ng0197-62 · DOI · Paper page
  52. Lindblad, 1996, An expanded CAG repeat sequence in spinocerebellar ataxia type 7, Genome Res., 6, 965, 10.1101/gr.6.10.965 · DOI · Paper page
  53. Koide, 1999, A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: A new polyglutamine disease?, Hum. Mol. Genet., 8, 2047, 10.1093/hmg/8.11.2047 · DOI · Paper page
  54. Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat. Genet., 18, 164, 10.1038/ng0298-164 · DOI · Paper page
  55. Stromme, 2002, Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy, Nat. Genet., 30, 441, 10.1038/ng862 · DOI · Paper page
  56. Beysen, 2003, FOXL2 and BPES: Mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation, Am. J. Hum. Genet., 72, 478, 10.1086/346118 · DOI · Paper page
  57. Mundlos, 1997, Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia, Cell, 89, 773, 10.1016/S0092-8674(00)80260-3 · DOI · Paper page
  58. Amiel, 2003, Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome, Nat. Genet., 33, 459, 10.1038/ng1130 · DOI · Paper page
  59. Goodman, 2000, Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome, Am. J. Hum. Genet., 67, 197, 10.1086/302961 · DOI · Paper page
  60. Brown, 1998, Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired, Nat. Genet., 20, 180, 10.1038/2484 · DOI · Paper page
  61. Muragaki, 1996, Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13, Science, 272, 548, 10.1126/science.272.5261.548 · DOI · Paper page
  62. Kato, 2004, Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation, Hum. Mutat., 23, 147, 10.1002/humu.10310 · DOI · Paper page
  63. Laumonnier, 2002, Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency, Am. J. Hum. Genet., 71, 1450, 10.1086/344661 · DOI · Paper page
  64. McLoughlin, 2019, Pathogenesis of SCA3 and implications for other polyglutamine diseases, Neurobiol. Dis., 134, 104635, 10.1016/j.nbd.2019.104635 · DOI · Paper page
  65. Rouleau, 2007, Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies, Biochim. Biophys. Acta, 1772, 173, 10.1016/j.bbadis.2006.10.003 · DOI
  66. Hughes, 2013, Molecular pathology of polyalanine expansion disorders: New perspectives from mouse models, Methods Mol. Biol., 1017, 135, 10.1007/978-1-62703-438-8_10 · DOI
  67. Massey, 2018, The central role of DNA damage and repair in CAG repeat diseases, Dis. Model. Mech., 11, dmm031930, 10.1242/dmm.031930 · DOI
  68. Quinodoz, 2021, RNA promotes the formation of spatial compartments in the nucleus, Cell, 184, 5775, 10.1016/j.cell.2021.10.014 · DOI · Paper page
  69. Wiedner, 2021, It’s not just a phase: Function and characteristics of RNA-binding proteins in phase separation, Nat. Struct. Mol. Biol., 28, 465, 10.1038/s41594-021-00601-w · DOI · Paper page
  70. Nelson, 2013, The unstable repeats—Three evolving faces of neurological disease, Neuron, 77, 825, 10.1016/j.neuron.2013.02.022 · DOI · Paper page
  71. Li, 2015, Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus, Hum. Mol. Genet., 24, 6932
  72. Mankodi, 2000, Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat, Science, 289, 1769, 10.1126/science.289.5485.1769 · DOI · Paper page
  73. Lee, 2013, Compound loss of muscleblind-like function in myotonic dystrophy, EMBO Mol. Med., 5, 1887, 10.1002/emmm.201303275 · DOI · Paper page
  74. Jain, 2017, RNA phase transitions in repeat expansion disorders, Nature, 546, 243, 10.1038/nature22386 · doi:10.1038/nature22386
  75. Hall, 2016, RNA as a fundamental component of interphase chromosomes: Could repeats prove key?, Curr. Opin. Genet. Dev., 37, 137, 10.1016/j.gde.2016.04.005 · DOI
  76. Zu, 2011, Non-ATG-initiated translation directed by microsatellite expansions, Proc. Natl. Acad. Sci. USA, 108, 260, 10.1073/pnas.1013343108 · DOI · Paper page
  77. Cleary, 2018, Repeat-associated non-ATG (RAN) translation, J. Biol. Chem., 293, 16127, 10.1074/jbc.R118.003237 · DOI
  78. Cho, 2005, Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF, Mol. Cell, 20, 483, 10.1016/j.molcel.2005.09.002 · DOI · Paper page
  79. Ladd, 2007, An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals, Hum. Mol. Genet., 16, 3174, 10.1093/hmg/ddm293 · DOI · Paper page
  80. Zu, 2013, RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia, Proc. Natl. Acad. Sci. USA, 110, E4968, 10.1073/pnas.1315438110 · DOI · Paper page
  81. Castro, A.F., Loureiro, J.R., Bessa, J., and Silveira, I. (2020). Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries. Genes, 11. · DOI
  82. Plys, 2018, Dynamic condensates activate transcription, Science, 361, 329, 10.1126/science.aau4795 · DOI
  83. Ishikawa, 2019, Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31), Neurotherapeutics, 16, 1106, 10.1007/s13311-019-00804-6 · DOI
  84. Loureiro, 2019, Mutational mechanism for DAB1 (ATTTC)n insertion in SCA37: ATTTT repeat lengthening and nucleotide substitution, Hum. Mutat., 40, 404, 10.1002/humu.23704 · DOI
  85. Klockgether, 2019, Spinocerebellar ataxia, Nat. Rev. Dis. Primers, 5, 24, 10.1038/s41572-019-0074-3 · DOI · Paper page
  86. Huang, 2019, Why do so many genetic insults lead to Purkinje Cell degeneration and spinocerebellar ataxia?, Neurosci. Lett., 688, 49, 10.1016/j.neulet.2018.02.004 · DOI
  87. Buijsen, 2019, Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias, Neurotherapeutics, 16, 263, 10.1007/s13311-018-00696-y · DOI
  88. Lin, 2003, SCA10 and ATTCT repeat expansion: Clinical features and molecular aspects, Cytogenet. Genome Res., 100, 184, 10.1159/000072853 · DOI
  89. Teive, 2004, Clinical phenotype of Brazilian families with spinocerebellar ataxia 10, Neurology, 63, 1509, 10.1212/01.WNL.0000142109.62056.57 · doi:10.1212/01.wnl.0000142109.62056.57
  90. Alonso, 2006, Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10, Neurology, 66, 1602, 10.1212/01.wnl.0000216266.30177.bb · doi:10.1212/01.wnl.0000216266.30177.bb
  91. Rasmussen, 2001, Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10, Ann. Neurol., 50, 234, 10.1002/ana.1081 · DOI
  92. Almeida, T., Alonso, I., Martins, S., Ramos, E.M., Azevedo, L., Ohno, K., Amorim, A., Saraiva-Pereira, M.L., Jardim, L.B., and Matsuura, T. (2009). Ancestral origin of the ATTCT repeat expansion in spinocerebellar ataxia type 10 (SCA10). PLoS ONE, 4. · DOI
  93. Bushara, K., Bower, M., Liu, J., McFarland, K.N., Landrian, I., Hutter, D., Teive, H.A., Rasmussen, A., Mulligan, C.J., and Ashizawa, T. (2013). Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry. PLoS ONE, 8. · DOI
  94. Leonardi, 2014, Spinocerebellar ataxia type 10 in Peru: The missing link in the Amerindian origin of the disease, J. Neurol., 261, 1691, 10.1007/s00415-014-7394-8 · DOI
  95. Xia, 2015, Bolivian kindred with combined spinocerebellar ataxia types 2 and 10, Acta Neurol. Scand., 132, 139, 10.1111/ane.12371 · doi:10.1111/ane.12371
  96. Castilhos, 2020, Genetic Analysis of Hereditary Ataxias in Peru Identifies SCA10 Families with Incomplete Penetrance, Cerebellum, 19, 208, 10.1007/s12311-019-01098-2 · DOI
  97. Wang, 2015, Spinocerebellar ataxia type 10 in Chinese Han, Neurol. Genet., 1, e26, 10.1212/NXG.0000000000000026 · doi:10.1212/nxg.0000000000000026
  98. Naito, H., Takahashi, T., Kamada, M., Morino, H., Yoshino, H., Hattori, N., Maruyama, H., Kawakami, H., and Matsumoto, M. (2017). First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China. PLoS ONE, 12. · DOI
  99. Waragai, 2006, Ataxin 10 induces neuritogenesis via interaction with G-protein beta2 subunit, J. Neurosci. Res., 83, 1170, 10.1002/jnr.20807 · DOI
  100. Matsuura, 2006, Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: Repeat purity as a disease modifier?, Am. J. Hum. Genet., 78, 125, 10.1086/498654 · DOI
  101. McFarland, K.N., Liu, J., Landrian, I., Godiska, R., Shanker, S., Yu, F., Farmerie, W.G., and Ashizawa, T. (2015). SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS ONE, 10. · DOI
  102. McFarland, 2014, Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures, Neurogenetics, 15, 59, 10.1007/s10048-013-0385-6 · doi:10.1007/s10048-013-0385-6
  103. Hashem, V., Tiwari, A., Bewick, B., Teive, H.A.G., Moscovich, M., Schuele, B., Bushara, K., Bower, M., Rasmussen, A., and Tsai, Y.C. (2020). Pulse-Field capillary electrophoresis of repeat-primed PCR amplicons for analysis of large repeats in Spinocerebellar Ataxia Type 10. PLoS ONE, 15. · doi:10.1371/journal.pone.0231746
  104. Kurosaki, 2009, Alu-mediated acquisition of unstable ATTCT pentanucleotide repeats in the human ATXN10 gene, Mol. Biol. Evol., 26, 2573, 10.1093/molbev/msp172 · DOI
  105. Wakamiya, 2006, The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10, Neurology, 67, 607, 10.1212/01.wnl.0000231140.26253.eb · DOI
  106. White, M.C., Gao, R., Xu, W., Mandal, S.M., Lim, J.G., Hazra, T.K., Wakamiya, M., Edwards, S.F., Raskin, S., and Teive, H.A. (2010). Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10. PLoS Genet., 6. · DOI · Paper page
  107. White, 2012, Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: A toxic RNA gain-of-function model, J. Neurosci. Res., 90, 706, 10.1002/jnr.22786 · doi:10.1002/jnr.22786
  108. Ishikawa, 2011, Pentanucleotide repeats at the spinocerebellar ataxia type 31 (SCA31) locus in Caucasians, Neurology, 77, 1853, 10.1212/WNL.0b013e3182377e3a · DOI
  109. Sakai, 2010, Analysis of an insertion mutation in a cohort of 94 patients with spinocerebellar ataxia type 31 from Nagano, Japan, Neurogenetics, 11, 409, 10.1007/s10048-010-0245-6 · doi:10.1007/s10048-010-0245-6
  110. Yoshida, 2017, Inter-generational instability of inserted repeats during transmission in spinocerebellar ataxia type 31, J. Hum. Genet., 62, 923, 10.1038/jhg.2017.63 · doi:10.1038/jhg.2017.63
  111. Lee, 2012, SCA31 is rare in the Chinese population on Taiwan, Neurobiol. Aging, 33, 426.e23, 10.1016/j.neurobiolaging.2010.10.012 · doi:10.1016/j.neurobiolaging.2010.10.012
  112. Ouyang, 2012, Spinocerebellar ataxia type 31 exists in northeast China, J. Neurol. Sci., 316, 164, 10.1016/j.jns.2012.02.005 · doi:10.1016/j.jns.2012.02.005
  113. Niimi, 2013, Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis, Neuropathology, 33, 600, 10.1111/neup.12032 · DOI
  114. Ishiguro, 2017, Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31, Neuron, 94, 108, 10.1016/j.neuron.2017.02.046 · DOI · Paper page
  115. Shibata, 2021, Small molecule targeting r(UGGAA)n disrupts RNA foci and alleviates disease phenotype in Drosophila model, Nat. Commun., 12, 236, 10.1038/s41467-020-20487-4 · DOI
  116. Ninomiya, 2020, LncRNA-dependent nuclear stress bodies promote intron retention through SR protein phosphorylation, EMBO J., 39, e102729, 10.15252/embj.2019102729 · DOI · Paper page
  117. Loureiro, 2018, A repeat-primed PCR assay for pentanucleotide repeat alleles in spinocerebellar ataxia type 37, J. Hum. Genet., 63, 981, 10.1038/s10038-018-0474-3 · doi:10.1038/s10038-018-0474-3
  118. Stevanin, 2013, New subtype of spinocerebellar ataxia with altered vertical eye movements mapping to chromosome 1p32, JAMA Neurol., 70, 764, 10.1001/jamaneurol.2013.2311 · DOI
  119. Rabano, 2018, Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37, Brain, 141, 1981, 10.1093/brain/awy137 · DOI · Paper page
  120. Chung, 1993, Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I, Nat. Genet., 5, 254, 10.1038/ng1193-254 · DOI · Paper page
  121. Ramos, 2010, Common Origin of Pure and Interrupted Repeat Expansions in Spinocerebellar Ataxia Type 2 (SCA2), Am. J. Med. Genet. Part B Neuropsychiatr. Genet., 153B, 524, 10.1002/ajmg.b.31013 · doi:10.1002/ajmg.b.31013
  122. Liquori, 2003, Myotonic dystrophy type 2: Human founder haplotype and evolutionary conservation of the repeat tract, Am. J. Hum. Genet., 73, 849, 10.1086/378720 · DOI
  123. Szmulewicz, 2016, Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS), Neurol. Clin. Pract., 6, 61, 10.1212/CPJ.0000000000000215 · DOI
  124. Akcimen, 2019, Investigation of the RFC1 Repeat Expansion in a Canadian and a Brazilian Ataxia Cohort: Identification of Novel Conformations, Front. Genet., 10, 1219, 10.3389/fgene.2019.01219 · DOI
  125. Scriba, 2020, A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families, Brain, 143, 2904, 10.1093/brain/awaa263 · DOI
  126. Beecroft, 2020, A Maori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele, Brain, 143, 2673, 10.1093/brain/awaa203 · DOI
  127. Kurosaki, T., Ueda, S., Ishida, T., Abe, K., Ohno, K., and Matsuura, T. (2012). The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome. PLoS ONE, 7. · DOI
  128. Pastore, 2013, Frataxin: A protein in search for a function, J. Neurochem., 126, 43, 10.1111/jnc.12220 · DOI · Paper page
  129. Sharifi, 2018, Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review, Tremor Other Hyperkinet. Mov., 8, 503, 10.5334/tohm.434 · DOI
  130. Depienne, 2010, Familial cortical myoclonic tremor with epilepsy: The third locus (FCMTE3) maps to 5p, Neurology, 74, 2000, 10.1212/WNL.0b013e3181e396a8 · DOI
  131. Striano, 2009, 1H-MR spectroscopy indicates prominent cerebellar dysfunction in benign adult familial myoclonic epilepsy, Epilepsia, 50, 1491, 10.1111/j.1528-1167.2008.01900.x · doi:10.1111/j.1528-1167.2008.01900.x
  132. Bour, 2007, Decreased cortical inhibition and yet cerebellar pathology in ‘familial cortical myoclonic tremor with epilepsy’, Mov. Disord., 22, 2378, 10.1002/mds.21738 · DOI
  133. Buijink, 2016, Cerebellar Atrophy in Cortical Myoclonic Tremor and Not in Hereditary Essential Tremor-a Voxel-Based Morphometry Study, Cerebellum, 15, 696, 10.1007/s12311-015-0734-0 · DOI
  134. Striano, 2013, Autosomal dominant cortical tremor, myoclonus, and epilepsy: Is the origin in the cerebellum? Editorial, Cerebellum, 12, 145, 10.1007/s12311-012-0419-x · doi:10.1007/s12311-012-0419-x
  135. Mikami, 1999, Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1, Am. J. Hum. Genet., 65, 745, 10.1086/302535 · DOI · Paper page
  136. Plaster, 1999, Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24, Neurology, 53, 1180, 10.1212/WNL.53.6.1180 · DOI
  137. Cen, 2018, Intronic pentanucleotide TTTCA repeat insertion in the SAMD12 gene causes familial cortical myoclonic tremor with epilepsy type 1, Brain, 141, 2280, 10.1093/brain/awy160 · DOI
  138. Cen, 2019, Intronic (TTTGA)n insertion in SAMD12 also causes familial cortical myoclonic tremor with epilepsy, Mov. Disord., 34, 1571, 10.1002/mds.27832 · DOI
  139. Lei, 2019, TTTCA repeat expansion causes familial cortical myoclonic tremor with epilepsy, Eur. J. Neurol., 26, 513, 10.1111/ene.13848 · DOI
  140. Zeng, 2019, Long-read sequencing identified intronic repeat expansions in SAMD12 from Chinese pedigrees affected with familial cortical myoclonic tremor with epilepsy, J. Med. Genet., 56, 265, 10.1136/jmedgenet-2018-105484 · DOI · Paper page
  141. Mizuguchi, 2019, Detecting a long insertion variant in SAMD12 by SMRT sequencing: Implications of long-read whole-genome sequencing for repeat expansion diseases, J. Hum. Genet., 64, 191, 10.1038/s10038-018-0551-7 · DOI
  142. Bennett, 2020, Familial adult myoclonic epilepsy type 1 SAMD12 TTTCA repeat expansion arose 17,000 years ago and is present in Sri Lankan and Indian families, Eur. J. Hum. Genet., 28, 973, 10.1038/s41431-020-0606-z · DOI
  143. Yeetong, 2021, Founder effect of the TTTCA repeat insertions in SAMD12 causing BAFME1, Eur. J. Hum. Genet., 29, 343, 10.1038/s41431-020-00729-1 · doi:10.1038/s41431-020-00729-1
  144. Guerrini, 2001, Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2, Brain, 124, 2459, 10.1093/brain/124.12.2459 · DOI · Paper page
  145. Henden, 2016, Identity by descent fine mapping of familial adult myoclonus epilepsy (FAME) to 2p11.2-2q11.2, Hum. Genet., 135, 1117, 10.1007/s00439-016-1700-8 · DOI
  146. Bouteiller, 2008, Refinement of the 2p11.1-q12.2 locus responsible for cortical tremor associated with epilepsy and exclusion of candidate genes, Neurogenetics, 9, 69, 10.1007/s10048-007-0107-z · doi:10.1007/s10048-007-0107-z
  147. Tankard, 2018, Detecting Expansions of Tandem Repeats in Cohorts Sequenced with Short-Read Sequencing Data, Am. J. Hum. Genet., 103, 858, 10.1016/j.ajhg.2018.10.015 · DOI · Paper page
  148. Dashnow, 2018, STRetch: Detecting and discovering pathogenic short tandem repeat expansions, Genome Biol., 19, 121, 10.1186/s13059-018-1505-2 · DOI · Paper page
  149. Doi, 2014, Rapid detection of expanded short tandem repeats in personal genomics using hybrid sequencing, Bioinformatics, 30, 815, 10.1093/bioinformatics/btt647 · DOI
  150. Yeetong, 2013, A newly identified locus for benign adult familial myoclonic epilepsy on chromosome 3q26.32-3q28, Eur. J. Hum. Genet., 21, 225, 10.1038/ejhg.2012.133 · doi:10.1038/ejhg.2012.133
  151. Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 · DOI · Paper page
  152. Deininger, 2011, Alu elements: Know the SINEs, Genome Biol., 12, 236, 10.1186/gb-2011-12-12-236 · DOI · Paper page
  153. Kelkar, 2011, A matter of life or death: How microsatellites emerge in and vanish from the human genome, Genome Res., 21, 2038, 10.1101/gr.122937.111 · DOI
  154. Clark, 2004, Expansion of GAA triplet repeats in the human genome: Unique origin of the FRDA mutation at the center of an Alu, Genomics, 83, 373, 10.1016/j.ygeno.2003.09.001 · DOI
  155. Chen, 2017, ALUternative Regulation for Gene Expression, Trends Cell Biol., 27, 480, 10.1016/j.tcb.2017.01.002 · DOI
  156. Lubelsky, 2018, Sequences enriched in Alu repeats drive nuclear localization of long RNAs in human cells, Nature, 555, 107, 10.1038/nature25757 · DOI · Paper page
  157. Hammond, 2021, Delivery of oligonucleotide-based therapeutics: Challenges and opportunities, EMBO Mol. Med., 13, e13243, 10.15252/emmm.202013243 · DOI · Paper page
  158. Crooke, 2021, Antisense technology: A review, J. Biol. Chem., 296, 100416, 10.1016/j.jbc.2021.100416 · DOI · Paper page
  159. Scoles, 2019, Antisense oligonucleotides: A primer, Neurol. Genet., 5, e323, 10.1212/NXG.0000000000000323 · DOI · Paper page
  160. Silva, 2020, Antisense oligonucleotide therapeutics in neurodegenerative diseases: The case of polyglutamine disorders, Brain, 143, 407, 10.1093/brain/awz328 · DOI · Paper page
  161. Kuijper, 2021, Opportunities and challenges for antisense oligonucleotide therapies, J. Inherit. Metab. Dis., 44, 72, 10.1002/jimd.12251 · DOI
  162. Oliveira, 2015, Recent advances in characterization of nonviral vectors for delivery of nucleic acids: Impact on their biological performance, Expert Opin. Drug Deliv., 12, 27, 10.1517/17425247.2014.945421 · DOI
  163. Evers, 2015, Antisense oligonucleotides in therapy for neurodegenerative disorders, Adv. Drug Deliv. Rev., 87, 90, 10.1016/j.addr.2015.03.008 · DOI · Paper page
  164. Friedrich, 2018, Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles, JCI Insight, 3, e123193, 10.1172/jci.insight.123193 · DOI · Paper page
  165. McLoughlin, 2018, Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice, Ann. Neurol., 84, 64, 10.1002/ana.25264 · DOI · Paper page
  166. Moore, 2017, Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models, Mol. Ther. Nucleic Acids, 7, 200, 10.1016/j.omtn.2017.04.005 · DOI · Paper page
  167. Toonen, 2016, Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3, Sci. Rep., 6, 35200, 10.1038/srep35200 · DOI
  168. Evers, 2013, Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon, Neurobiol. Dis., 58, 49, 10.1016/j.nbd.2013.04.019 · DOI
  169. Niu, 2018, Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7, Sci. Transl. Med., 10, eaap8677, 10.1126/scitranslmed.aap8677 · DOI · Paper page
  170. Yadava, 2021, Modeling muscle regeneration in RNA toxicity mice, Hum. Mol. Genet., 30, 1111, 10.1093/hmg/ddab108 · DOI
  171. Liu, 2021, Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models, Nat. Commun., 12, 847, 10.1038/s41467-021-21112-8 · DOI
  172. Toonen, 2017, Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice, Mol. Ther. Nucleic Acids, 8, 232, 10.1016/j.omtn.2017.06.019 · DOI
  173. Kingwell, 2021, Double setback for ASO trials in Huntington disease, Nat. Rev. Drug Discov., 20, 412, 10.1038/d41573-021-00088-6 · DOI
  174. Yang, 2016, Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10, Nat. Commun., 7, 11647, 10.1038/ncomms11647 · DOI

Cited by

See all 28

Metadata

Authors
Loureiro, J. R., Castro, A. F., Figueiredo, A. S., & Silveira, I.
Affiliations
Genetics of Cognitive Dysfunction Laboratory, i3S- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal
Venue
Cells
Publisher
MDPI AG
Published
2022-01-08
Volume
11
Issue
2
Pages
205
ISSN
2073-4409
Cited by
28
References
9
Language
en
Funders
Fundação para a Ciência e Tecnologia (POCI-01-0145-FEDER-029255 (PTDC/MED-GEN/29255/2017))

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Mechanisms in Pentanucleotide Repeat Diseases. https://app.cochat.ai/papers/10.3390/cells11020205
The paper
Loureiro, J. R., Castro, A. F., Figueiredo, A. S., & Silveira, I. (2022). Molecular Mechanisms in Pentanucleotide Repeat Diseases. Cells. https://doi.org/10.3390/cells11020205

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.